Novar Corporation
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Tolerance of Full Field Peripheral Defocus Spectacles for the Control of Myopia Progression (Myofix Study) (NCT07092072) | Novar Corporation | 2023-05-23 |
Track Novar Corporation automatically
Every clearance here is in the API, with alerts when new ones post.